| Literature DB >> 24292793 |
Taku Kaitsuka1, Hirofumi Noguchi, Nobuaki Shiraki, Takuya Kubo, Fan-Yan Wei, Farzana Hakim, Shoen Kume, Kazuhito Tomizawa.
Abstract
Embryonic stem (ES) and induced pluripotent stem (iPS) cells have potential applications to regenerative medicine for diabetes; however, a useful and safe way to generate pancreatic β cells has not been developed. In this study, we tried to establish an effective method of differentiation through the protein transduction of three transcription factors (Pdx1, NeuroD, and MafA) important to pancreatic β cell development. The method poses no risk of unexpected genetic modifications in target cells. Transduction of the three proteins induced the differentiation of mouse ES and mouse iPS cells into insulin-producing cells. Furthermore, a laminin-5-rich extracellular matrix efficiently induced differentiation under feeder-free conditions. Cell differentiation was confirmed with the expression of the insulin 1 gene in addition to marker genes in pancreatic β cells, the differentiated cells secreted glucose-responsive C-peptide, and their transplantation restored normoglycemia in diabetic mice. Moreover, Pdx1 protein transduction had facilitative effects on differentiation into pancreatic endocrine progenitors from human iPS cells. These results suggest the direct delivery of recombinant proteins and treatment with laminin-5-rich extracellular matrix to be useful for the generation of insulin-producing cells.Entities:
Keywords: Diabetes; Embryonic stem cells; Induced pluripotent stem cells; Pancreatic differentiation; Transcription factors
Mesh:
Substances:
Year: 2013 PMID: 24292793 PMCID: PMC3902286 DOI: 10.5966/sctm.2013-0075
Source DB: PubMed Journal: Stem Cells Transl Med ISSN: 2157-6564 Impact factor: 6.940